Dr. David Phillips, MD
What this data tells you about Dr. Phillips
Dr. David Phillips is an urology physician in Austin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Phillips performed 17,718 Medicare services across 2,493 unique beneficiaries.
Between the years covered by Open Payments, Dr. Phillips received a total of $12,935 from 61 pharmaceutical and/or device companies across 589 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Phillips is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 12,000 | $19 | $43 |
| Contrast dye for imaging (iodine-based) | 1,100 | $0 | $1 |
| Chronic care management, first 20 min/month | 911 | $47 | $77 |
| Office visit, established patient (30-39 min) | 858 | $93 | $249 |
| Automated urinalysis | 644 | $2 | $7 |
| Blood draw (venipuncture) | 412 | $8 | $15 |
| Chronic care management, additional 20 min/month | 359 | $38 | $77 |
| Office visit, established patient (20-29 min) | 335 | $60 | $168 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 264 | $135 | $2,000 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 189 | $47 | $82 |
| Bladder ultrasound after voiding | 144 | $8 | $44 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 78 | $58 | $175 |
| New patient office visit (45-59 min) | 74 | $116 | $380 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 61 | $28 | $76 |
| Diagnostic exam of bladder and urethra using an endoscope | 58 | $160 | $477 |
| Hospital follow-up visit, moderate complexity | 48 | $61 | $167 |
| Ceftriaxone antibiotic injection | 44 | $0 | $3 |
| Office visit, established patient, complex (40-54 min) | 30 | $118 | $336 |
| Initial hospital admission, moderate complexity | 24 | $100 | $316 |
| New patient office visit (30-44 min) | 21 | $82 | $250 |
| Biopsy of prostate gland | 17 | $153 | $508 |
| Ultrasound scan of pelvic region through rectum | 17 | $111 | $250 |
| Drug injection, under skin or into muscle | 17 | $10 | $59 |
| Urinalysis with microscopic exam | 13 | $3 | $10 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Phillips is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (low-engagement, top 16%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Phillips experienced with denosumab injection (prolia/xgeva)?
Does Dr. Phillips receive payments from pharmaceutical companies?
How do Dr. Phillips's costs compare to other urology physicians in Austin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology